Back to Global NewsPublished: 1 Mar 2026Download AppJoin TelegramWhy Septerna's SEP-631 Could Redefine Urticaria Treatment – An Investor’s Early Warning#Septerna#SEP-631#Urticaria#GPCR#Biotech#Investing#Phase 1#Mast CellDownload AppJoin CommunityShare Article